Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping
- DOI
- 10.1016/j.ejmech.2018.01.034
- Published
- 2018-02
- Container
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2018.01.034,
title = {Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping},
author = {Wei Tuo and Mélanie Bollier and Natascha Leleu-Chavain and Lucas Lemaire and Amélie Barczyk and Xavier Dezitter and Frédérique Klupsch and Fabien Szczepanski and John Spencer and Philippe Chavatte and Régis Millet},
year = {2018},
journal = {European Journal of Medicinal Chemistry},
doi = {10.1016/j.ejmech.2018.01.034},
url = {https://doi.org/10.1016/j.ejmech.2018.01.034}
}RIS
TY - JOUR TI - Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping AU - Wei Tuo AU - Mélanie Bollier AU - Natascha Leleu-Chavain AU - Lucas Lemaire AU - Amélie Barczyk AU - Xavier Dezitter AU - Frédérique Klupsch AU - Fabien Szczepanski AU - John Spencer AU - Philippe Chavatte AU - Régis Millet PY - 2018 JO - European Journal of Medicinal Chemistry DO - 10.1016/j.ejmech.2018.01.034 UR - https://doi.org/10.1016/j.ejmech.2018.01.034 ER -
APA
Tuo, W., Bollier, M., Leleu-Chavain, N., Lemaire, L., Barczyk, A., Dezitter, X., Klupsch, F., Szczepanski, F., Spencer, J., Chavatte, P., & Millet, R. (2018). Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2018.01.034
Source records
- crossref · retrieved 2026-11-10T18:57:20.937Z